Sign in
4

Changes in Ownership

Immuneering Corp Filed Acc 0001628280-24-024943

Options or other derivatives

  • Chief Business Officer acquired 225,500 shares (grant or award)
  • Chief Business Officer returned 225,500 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Brakewood Harold Eugene Chief Business Officer 2024-05-21 Returned to the company · Stock Option −165,000 0 D
Brakewood Harold Eugene Chief Business Officer 2024-05-21 Grant or award · Stock Option +165,000 165,000 D
Brakewood Harold Eugene Chief Business Officer 2024-05-21 Returned to the company · Stock Option −60,500 0 D
Brakewood Harold Eugene Chief Business Officer 2024-05-21 Grant or award · Stock Option +60,500 60,500 D
Loading xslF345X05/wk-form4_1716495333.xml…